Drug Profile
MucoRice CTB - Astellas/The Institute of Medical Science/The University of Tokyo
Alternative Names: MucoRice-CTBLatest Information Update: 21 Feb 2020
Price :
$50
*
At a glance
- Originator Institute of Medical Science, The University of Tokyo
- Developer Astellas Pharma; Institute of Medical Science, The University of Tokyo
- Class Antidiarrhoeals; Cholera vaccines; Escherichia coli vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Escherichia coli infections
- Discontinued Cholera